{"id":53,"date":"2017-12-21T08:42:30","date_gmt":"2017-12-21T08:42:30","guid":{"rendered":"http:\/\/unicorp.solutions\/index.php\/2017\/12\/21\/how-cuba-became-a-biopharma-juggernaut\/"},"modified":"2017-12-21T08:42:30","modified_gmt":"2017-12-21T08:42:30","slug":"how-cuba-became-a-biopharma-juggernaut","status":"publish","type":"post","link":"https:\/\/unicorp.solutions\/index.php\/2017\/12\/21\/how-cuba-became-a-biopharma-juggernaut\/","title":{"rendered":"How Cuba Became a Biopharma Juggernaut"},"content":{"rendered":"<section class=\"wpb-content-wrapper\"><p>[vc_row][vc_column][tm_heading tag=&#8221;h5&#8243; custom_google_font=&#8221;&#8221; font_weight=&#8221;600&#8243; text=&#8221;The sophisticated system, which the small island nation developed despite limited resources and access to international markets, holds about 1,200 international patents and sells medicine and equipment to more than 50 countries.&#8221; line_height=&#8221;1.4&#8243;][tm_spacer size=&#8221;lg:25&#8243;][tm_heading tag=&#8221;div&#8221; custom_google_font=&#8221;&#8221; text=&#8221;We hear little about the Cuban biopharmaceutical industry, but it merits attention. The industry is entirely publicly funded and managed, and is a key component of one of the most efficient public health care systems in the world. Its goal is to develop drugs of strategic importance to the health care of all people.&#8221;][tm_spacer size=&#8221;lg:63&#8243;][vc_row_inner][vc_column_inner width=&#8221;3\/12&#8243;][tm_image image=&#8221;875&#8243;][tm_spacer size=&#8221;sm:30&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;9\/12&#8243;][tm_heading tag=&#8221;h5&#8243; custom_google_font=&#8221;&#8221; font_weight=&#8221;600&#8243; text=&#8221;Use psychological pricing methods.&#8221; line_height=&#8221;1.4&#8243;][tm_spacer size=&#8221;lg:23&#8243;][tm_heading tag=&#8221;div&#8221; custom_google_font=&#8221;&#8221; text=&#8221;But there\u2019s something missing in this outsiders\u2019 view of the country, as it can\u2019t account for the enormous successes of Cuba\u2019s biopharmaceutical industry and health care systems. In light of ongoing debates in the U.S. and other nations about the role of government in ensuring people have the health care coverage they need, Cuba\u2019s experience could prove instructive.&#8221;][tm_spacer size=&#8221;xs:30;lg:35&#8243;][tm_heading tag=&#8221;div&#8221; custom_google_font=&#8221;&#8221; text=&#8221;High-tech industrial development isn\u2019t the first thing that comes to mind for many when thinking of Cuba. The island nation more commonly invokes visions of a stunning place frozen in time: Crumbling colonial buildings sit alongside beautiful beaches, while 1950s American cars line city streets awash in the sun\u2019s afternoon glow. Here, life is embedded in a state-controlled and mostly inefficient economy that\u2019s virtually detached from global technology networks.&#8221;][\/vc_column_inner][\/vc_row_inner][tm_spacer size=&#8221;xs:30;lg:52&#8243;][tm_heading tag=&#8221;div&#8221; custom_google_font=&#8221;&#8221; text=&#8221;More recently, the CIMAvax-EGF vaccine for lung cancer became the first Cuban biopharmaceutical product to earn the U.S. drug regulator\u2019s permission to carry out clinical trials on American soil. The product was developed by the Center for Molecular Immunology, which specializes in antibodies, cancer medicines, and other areas.&#8221;][tm_spacer size=&#8221;xs:30;lg:68&#8243;][vc_row_inner][vc_column_inner offset=&#8221;vc_col-md-6&#8243;][tm_heading tag=&#8221;h5&#8243; custom_google_font=&#8221;&#8221; font_weight=&#8221;600&#8243; text=&#8221;Demonstrate the differences&#8221; line_height=&#8221;1.4&#8243;][tm_spacer size=&#8221;lg:23&#8243;][tm_heading tag=&#8221;div&#8221; custom_google_font=&#8221;&#8221; text=&#8221;There is growing evidence of the Cuban biopharma industry\u2019s success. Local production covers more than 60% of finished pharmaceutical products used in the country, and the industry\u2019s trade balance has remained consistently positive for most of the period 1995-2015. &#8220;][tm_spacer size=&#8221;sm:30;lg:68&#8243;][tm_heading tag=&#8221;h5&#8243; custom_google_font=&#8221;&#8221; font_weight=&#8221;600&#8243; text=&#8221;Offer a money-back guarantee&#8221; line_height=&#8221;1.4&#8243;][tm_spacer size=&#8221;lg:23&#8243;][tm_heading tag=&#8221;div&#8221; custom_google_font=&#8221;&#8221; text=&#8221;Cuba\u2019s biopharma sector has been able to finance many programs carried out within the nation\u2019s public health system, and it is the main reason behind the affordability of the medical products supplied by the system.&#8221;][tm_spacer size=&#8221;sm:30;lg:68&#8243;][tm_heading tag=&#8221;h5&#8243; custom_google_font=&#8221;&#8221; font_weight=&#8221;600&#8243; text=&#8221;Test your offer and price, and be creative.&#8221; line_height=&#8221;1.4&#8243;][tm_spacer size=&#8221;lg:23&#8243;][tm_heading tag=&#8221;div&#8221; custom_google_font=&#8221;&#8221; text=&#8221;In terms of the biotechnology sector specifically, while Cuba\u2019s government does not publish extensive statistics on the matter, industry officials report that the Cuban biotech sector managed to maintain positive, if modest, cash flows at a time when overall cash flows of the industry worldwide had been mostly negative for decades.&#8221;][\/vc_column_inner][vc_column_inner offset=&#8221;vc_col-md-6&#8243;][tm_spacer size=&#8221;sm:40&#8243;][tm_image full_wide=&#8221;1&#8243; image=&#8221;876&#8243;][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/section>","protected":false},"excerpt":{"rendered":"<p>More recently, the CIMAvax-EGF vaccine for lung cancer became the first Cuban biopharmaceutical product to carry out clinical trials on American soil. <\/p>\n","protected":false},"author":1,"featured_media":47,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18],"tags":[26,28],"class_list":["post-53","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finance-accounting","tag-classic","tag-industry"],"views":256,"_links":{"self":[{"href":"https:\/\/unicorp.solutions\/index.php\/wp-json\/wp\/v2\/posts\/53","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/unicorp.solutions\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/unicorp.solutions\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/unicorp.solutions\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/unicorp.solutions\/index.php\/wp-json\/wp\/v2\/comments?post=53"}],"version-history":[{"count":0,"href":"https:\/\/unicorp.solutions\/index.php\/wp-json\/wp\/v2\/posts\/53\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/unicorp.solutions\/index.php\/wp-json\/wp\/v2\/media\/47"}],"wp:attachment":[{"href":"https:\/\/unicorp.solutions\/index.php\/wp-json\/wp\/v2\/media?parent=53"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/unicorp.solutions\/index.php\/wp-json\/wp\/v2\/categories?post=53"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/unicorp.solutions\/index.php\/wp-json\/wp\/v2\/tags?post=53"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}